Enrichment and analysis of Alzheimer's Aβ1-42 peptide in human plasma and whole blood

Journal of Neuroscience Methods

Volumn 182, Issue 2, 2009, Pages 260-265

  Ditto, Noah T ^a   Kline, Tiffany R ^a   Alfinito, Peter D ^a   Slemmon, J Randall ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Amyloid beta; ELISA; HPLC; Solid phase extraction

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; EDETIC ACID; POTASSIUM;

ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; MOLECULAR CHAPERONES; PEPTIDE FRAGMENTS; PLASMA; PROTEIN BINDING; SOLID PHASE EXTRACTION;

EID: 68249122394     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2009.05.025     Document Type: Article

References (34)

1. Abdullah L., Paris D., Luis C., Quadros A., Parrish J., Valdes L., et al. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels. Neurosci Lett 428 2-3 (2007) 53-58
2. Banks W.A., Robinson S.M., Verma S., and Morley J.E. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neuroscience 121 2 (2003) 487-492
3. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., et al. Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27 5 (2007) 909-918
4. Best J.D., Jay M.T., Out F., Churcher I., Reilly M., Morentin-Gutierrez P., et al. In vivo characterization of Aβ(40) changes in brain and cerebrospinal fluid using the novel gamma-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat. J Pharmacol Exp Ther 317 2 (2006) 786-790
5. Biere A.L., Ostaszewski B., Stimson E.R., Hyman T., Maggio J.E., and Selkoe D.J. Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 271 51 (1996) 32916-32922
6. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 265 26 (1990) 15977-15983
7. Chauhan V.P.S., Ray I., Chauhan A., and Wisniewski H.M. Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun 258 2 (1999) 241-246
8. Chen M., Inestrosa N.C., Ross G.S., and Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213 1 (1995) 96-103
9. Costa R., Gonçalves A., Saraiva M.J., and Cardoso I. Transthyretin binding to A-Beta peptide-impact on A-Beta fibrillogenesis and toxicity. FEBS Lett 582 6 (2008) 936-942
10. Cummings J.L. Alzheimer's disease. N Engl J Med 351 1 (2004) 56-67
11. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., and Holtzman D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295 5563 (2002) 2264-2267
12. Gilman S., Koller M., Black R.S., Jenkins L., Griffith S.G., Fox N.C., et al. Clinical effects of Aß immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64 9 (2005) 1553-1562
13. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120 1 (1984) 885-890
14. Hammad S.M., Ranganathan S., Loukinova E., Twal W.O., and Argraves W.S. Interaction of apolipoprotein J-amyloid-peptide complex with low density lipoprotein receptor-related protein-2/Megalin: a mechanism to prevent pathological accumulation of amyloid β-peptide. J Biol Chem 272 30 (1997) 18644-18649
15. Hansson O., Zetterberg H., Vanmechelen E., Vanderstichele H., Andreasson U., Londos E., et al. Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 29 1 (2008) 01-11
16. Kuo Y.M., Kokjohn T.A., Kalback W., Luehrs D., Galasko D.R., Chevallier N., et al. Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol 156 3 (2000) 797-805
17. Lanz T.A., and Schachter J.B. Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Aβ quantification following passive immunization with Aβ antibodies. J Neurosci Methods 169 1 (2008) 16-22
18. Li Q.X., Whyte S., Tanner J.E., Evin G., Beyreuther K., and Masters C.L. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab Invest 78 4 (1998) 461-469
19. Marcello E., Epis R., and Di Luca M. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis. Eur J Pharmacol 585 1 (2008) 109-118
20. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82 12 (1985) 4245-4249
21. Matsuoka Y., Saito M., LaFrancois J., Saito M., Gaynor K., Olm V., et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid. J Neurosci 23 1 (2003) 29-33
22. Mayeux R., Tang M.-X., Jacobs D.M., Manly J., Bell K., Merchant C., et al. Plasma amyloid β-peptide 1-41 and incipient Alzheimer's disease. Ann Neurol 46 3 (1999) 412-416
23. Monro O.R., Mackic J.B., Yamada S., Segal M.B., Ghiso J., Maurer C., et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 23 3 (2002) 405-412
24. Schlossmacher M.G., Ostaszewski B.L., Hecker L.I., Celi A., Haass C., Chin D., et al. Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging 13 3 (1992) 421-434
25. Schwarzman A.L., Gregori L., Vitek M.P., Lyubki S., Strittmatter W.J., Enghilde J.J., et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA 91 18 (1994) 8368-8372
26. Selkoe D.J. Alzheimer's disease: gene's, proteins, and therapy. Physiol Rev 81 2 (2001) 741-766
27. Siemers E.R., Dean R.A., Friedrich S., Ferguson-Sells L., Gonzales C., Farlow M.R., et al. Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase. Clin Neuropharmacol 30 6 (2007) 317-325
28. Skovronsky D.M., Lee V.M., and Pratico D. Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C. J Biol Chem 276 20 (2001) 17036-17043
29. Slemmon J.R., Hughes C.M., Campbell G.A., and Flood D.G. Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J. Neurosci 14 4 (1994) 2225-2235
30. Slemmon J.R., Painter C.L., Nadanaciva S., Catana F., Cook A., Motter R., et al. Distribution of Aβ peptide in whole blood. J Chromatogr B 846 1-2 (2007) 24-31
31. Tsuzuki K., Fukatsu R., Yamaguchi H., Tateno M., Imai K., Fujii N., et al. Transthyretin binds amyloid β peptides, Aβ1-42 and Aβ1-40 to form complex in the autopsied human kidney-possible role of transthyretin for Aβ sequestration. Neurosci Lett 281 2-3 (2000) 171-174
32. van Oijen M., Hofman A., Soares H., Koudstaal P., and Breteler M. Plasma Aβ1-40 and Aβ1-42 and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5 8 (2006) 655-660
33. Vanderstichele H., Van Kerschaver E., Hesse C., Davidsson P., Buyse M.A., Andreasen N., et al. Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7 4 (2000) 245-258
34. Zaghi J., Goldenson B., Inayathullah M., Lossinsky A.S., Masoumi A., Mahanian H.A.M., et al. Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol 117 2 (2009) 111-124